New York State Common Retirement Fund Has $18.82 Million Position in Humana Inc. (NYSE:HUM)

New York State Common Retirement Fund cut its holdings in shares of Humana Inc. (NYSE:HUM) by 8.8% during the fourth quarter, Holdings Channel reports. The fund owned 74,182 shares of the insurance provider’s stock after selling 7,165 shares during the quarter. New York State Common Retirement Fund’s holdings in Humana were worth $18,821,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in the business. Kentucky Retirement Systems Insurance Trust Fund increased its holdings in shares of Humana by 54.9% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 5,521 shares of the insurance provider’s stock worth $1,401,000 after acquiring an additional 1,956 shares during the last quarter. Kestra Investment Management LLC acquired a new position in shares of Humana during the 4th quarter worth approximately $49,000. Atria Wealth Solutions Inc. increased its holdings in shares of Humana by 21.1% during the 4th quarter. Atria Wealth Solutions Inc. now owns 1,610 shares of the insurance provider’s stock worth $409,000 after acquiring an additional 281 shares during the last quarter. Venturi Wealth Management LLC increased its holdings in shares of Humana by 628.4% during the 4th quarter. Venturi Wealth Management LLC now owns 692 shares of the insurance provider’s stock worth $176,000 after acquiring an additional 597 shares during the last quarter. Finally, D.A. Davidson & CO. increased its holdings in shares of Humana by 19.0% during the 4th quarter. D.A. Davidson & CO. now owns 1,283 shares of the insurance provider’s stock worth $326,000 after acquiring an additional 205 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.32% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of research reports. TD Cowen upped their price objective on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a report on Monday, November 4th. Barclays upped their price objective on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Wells Fargo & Company decreased their price objective on Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. Finally, Morgan Stanley decreased their price objective on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 12th. Nineteen investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, Humana presently has an average rating of “Hold” and an average target price of $285.68.

Humana Trading Down 5.7 %

Shares of HUM stock opened at $255.77 on Friday. The stock has a market cap of $30.80 billion, a price-to-earnings ratio of 25.71, a PEG ratio of 2.05 and a beta of 0.56. The stock has a 50-day moving average of $269.41 and a 200-day moving average of $290.00. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46.

Humana (NYSE:HUM) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.38%. Humana’s payout ratio is 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.